Blood-based markers may reveal Alzheimer’s disease ten years before symptoms show

Glass laboratory flasks on light table

Alzheimer’s disease begins decades before the onset of any symptoms, such as memory loss. Consequently, early diagnosis increases the chances of slowing the disease down with drugs. A new study on an inherited form of the disease shows that a protein called GFAP is a possible biomarker for very early stages of the disease. The study, conducted by researchers at Karolinska Institutet and published in the journal Brain, could one day lead to an earlier detection of this serious and common disease.

Simple, cost-effective injection can protect premature babies from cerebral palsy

Previous article

School garden-based interventions can improve metabolic parameters in children

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations